Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Urothelial bladder cancer… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour.

Artikel i vetenskaplig tidskrift
Författare Bülent Gunlusoy
Yasin Ceylan
Tansu Degirmenci
Zafer Kozacioglu
Tarık Yonguc
Halil Bozkurt
Özgu Aydogdu
Volkan Sen
Publicerad i Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Volym 9
Nummer/häfte 9-10
Sidor E727-30
ISSN 1911-6470
Publiceringsår 2015
Publicerad vid
Sidor E727-30
Språk en
Länkar dx.doi.org/10.5489/cuaj.3049
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämneskategorier Urologi och njurmedicin

Sammanfattning

The aim of the study is to reveal pathologic characteristics and clinical behaviour of patients 40 years old or younger diagnosed with and treated for urothelial bladder carcinoma.We retrospectively analyzed the clinical and pathologic data of 91 patients, initially diagnosed and treated at our institution from May 1996 to December 2014. Cancer recurrence was defined as new occurrence of bladder cancer at the same or different sites of the bladder. Cancer progression was defined as an increase in stage or grade in any of the recurrences.The mean age was 33.8 (range: 17-40) years. The pathological examination after transurethral resection revealed 83 (91.2%) patients with non-muscle invasive urothelial bladder cancer, and 8 (8.8%) patients with muscle invasive urothelial bladder cancer. According to the distribution of grade, there were 75, 4 and 12 patients with grade 1, grade 2 and grade 3 diseases, respectively. Initial cancer staging was: pTa with 40 patients (43.9%), pT1 with 43 patients (47.2%), pT2 with 7 patients (7.6%), and pT3 with 1 patient (1.2%). While 17 (18.6%) patients recurred in the follow-up, 10 (10.9%) patients had progression. There were no differences in recurrence and progression rates in the Ta and T1 stages between groups (p = 0.233, p = 0.511, respectively).The risk of progression increased as the number of relapses increased. The clinical behaviour of high-stage and high-grade disease in younger patients is similar to the older group.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?